The CAMadvocate course (http://www.cameducation.co.uk), which is delivered online, consists of 10 modules with video presentations, course notes, downloads, owner-focused tools, further online learning, and social media uploads.
The course is designed to help canine professionals improve their understanding of canine arthritis, and to define their role in the identification, diagnosis, and management of the condition.
Hannah Capon MRCVS, the founder of Canine Arthritis Management said: "Dog walkers, groomers, trainers, kennel owners, etc., are all influencers! They have the ability to support a long-term veterinary-derived management plan. Or they have the ability to destabilise it!
"Owners listen to these people because they have more available time; they may appear less like a business and more like a friendly service or even a peer; or they may offer advice that seems more convincing. Whatever the reason, we should harness their powers and ensure they are disseminating reliable information whilst servicing their own needs!"
Canine Arthritis Management believes that a multidisciplinary team is required to better manage this disease, that this includes professionals outside the veterinary practice, and by harnessing their influence, the profession can educate more owners, identify this disease earlier, action appropriate management plans and give owners more years with their pets.
Hannah added: "I hope the profession will support this initiative and consider applying it to other chronic diseases that are prone to misinformation due to lucrative product sales."
CommentA training course / qualification developed by a veterinary surgeon and designed to educate influencers. It's genius. Surely there's huge scope for this kind of initiative beyond canine arthritis? What do you think pet owners are most ill-informed about, where it could be really effective to better educate canine influencers, so that they in turn will pass it on. Post your thoughts here.
The company is encouraging owners to post a simple 'thank you' on Facebook with the hashtag #thankuvets.
Boehringer has also produced a thank you video, depicting a day in the life of an equine vet during these tough times.
Warren Ball, Equine Brand Manager at Boehringer Ingelheim Animal Health, said: “This year has been a year like no other, but equine vets throughout the country have carried on regardless of the challenges they face and are deserving of a huge thanks from all who need them.”
"Our ‘Thank You Vets’ initiative will show how appreciated each and every vet is by bringing together owners, trainers and others in the equine community."
To watch the video and see the thank you messages from owners, visit: https://www.facebook.com/equitopmyoplast/posts/2188633904615007
What a lovely initiative. Makes a change from the usual griping on Facebook.
The company has won the Institute of Student Employers (ISE) 'Best Graduate Onboarding and Induction Activities Programme.' (Dear god. Not to take anything away from Vets4Pets' considerable achievement, but is it just me that finds it like fingernails on a blackboard when people take a perfectly serviceable preposition like 'on board' and turn it into a verb?).
Gordon Dunn, People Director at Vets4Pets, said: “As a leading UK veterinary employer, we view it as our personal responsibility to fully prepare graduates at the beginning of their career. This includes, but isn’t limited to, ensuring they are equipped with the right skills and behaviours to forge their own individual career pathway, and increase the chances of them remaining in the profession.
"The induction and onboarding of our graduates forms the lynchpin of our programme, and clearly sets out what is to come. Being recognised for the work we’re doing to develop the next generation of veterinary talent is a huge celebration for us and is a testimony to the investment made and hard work over the last few years to develop and evolve a world-class development programme. We’re extremely proud to be recognised for this achievement.”
For the study, the researchers analysed rehoming adverts placed on the websites of 16 Dogs Trust and RSPCA centres in 2015 and 2018. Data was collected on 1793 dogs across the 16 centres.
The percentage of dogs classified as 'extreme brachycephalic' using the Kennel Club definition increased from 2.76% (n=24) in 2015 to 5.19% (n=48) in 2018.The researchers speculate that owners may be passing on the financial burden of caring for and treating chronic health issues in brachycephalic dogs to the rehoming charities.
Dr Anne Carter, Senior Lecturer in Animal Science at Nottingham Trent University said: "The increasing numbers and rising popularity of brachycephalic breeds is already influencing the demographic spread in rescue centres. This pattern that is likely to continue, particularly as these dogs reach 3–4 years old, which we have found is the most common age for dogs being relinquished.
"Differing breeds require highly contrasting intensities of care, housing, and particularly veterinary care. Owners may often choose brachycephalic dogs with limited consideration for their potential health conditions. These dogs then enter rescue centres, placing additional strain on resources due to cost of treatment and additional length of stay for recovery.”
Reference
Laura Padron Vega was struck off in December 2018 after dishonestly backdating two statutory Certificates of Competence submitted to the Food Standards Agency under the Welfare of Animals at the Time of Killing Regulations 2015.
She was also found to have failed in her duties as an OV because she was unprepared for, and unaware of, the new regulations and did not take adequate steps to ensure that the two people for whom she had given veterinary certification were licensed to perform slaughter in accordance with the regulations.
At the outset of the restoration hearing, Ms Padron Vega admitted her guilt and made representations that she appreciated the seriousness of her actions and that there was no chance of her repeating them. She also produced a number of testimonials, including some from former veterinary colleagues, in addition to evidence that she had endeavoured to keep up-to-date with her continuing professional development while off the Register although this had been difficult due to her financial circumstances.
In considering her application for restoration, the Committee found that Ms Padron Vega had accepted the reasons for her removal from the Register and the seriousness of the findings. It found that she was unlikely to repeat the behaviour and that her conduct had been entirely acceptable since she was removed from the Register. It also considered her financial and personal circumstances, noting the difficulty she had in securing well-paid, full-time employment since her removal from the Register, and the impact that this had on her being able to keep up-to-date with her continuing professional development.
However, the Committee expressed concerns over her efforts to keep up-to-date with the knowledge and skills she would need to return to practice and said she demonstrated “no real appreciation of what she needed to put in place to demonstrate that she can return to work safely”.
In particular it found that the CPD she had undertaken was unstructured and insufficient and that therefore she had not done enough at the present time to demonstrate that she was fit to be restored to the Register, especially as she signalled that, if restored, she hoped to work in small animal practice, an area that she had not worked in for some time.
Cerys Jones, chairing the Committee and speaking on its behalf, said: “While the Committee did not consider that the applicant was in a position to return to practice at this point, it did consider that if the applicant applies herself to a properly structured and focused Return to Practice Plan and is able to produce evidence of how she has fulfilled the requirements of that plan, then her application could prove successful within a short time.
"The outcome of the plan for a return to practice will need to ensure the continued protection of the welfare of animals as well as the interests of clients whose animals she might be called upon to treat and, most importantly, the public interest which is founded on a belief that the veterinary certification processes are beyond question or doubt."
In order to allow Ms Padron Vega sufficient time to develop this plan, the Committee adjourned the restoration hearing for seven months (until July 2021).
Ms Jones added: “This adjournment will afford [Ms Padron Vega] an early opportunity to reflect on the concerns of the Committee… and to return with a properly supported programme for the future which will show her understanding of the problems that are likely to face her on her return to practice and her proposals to meet those inevitable difficulties.”
The company says that CircoMax Myco offers the longest lasting combined protection on the EU market against PCV2 and M. hyopneumoniae pathogens. This reduces the PCV2 viral load in blood and lymphoid tissues, PCV2 fecal shedding, lymphoid tissue lesions associated with PCV2 infection, and lung lesions associated with M. hyopneumoniae infections.
Pig protection was demonstrated against porcine circovirus genotypes 2a, 2b and 2d and lasts for at least 23 weeks after vaccination in fattening pigs for both PCV2 and M. hyopneumoniae.
Monica Balasch, Director, Global Biologicals Development at Zoetis, said: "Porcine circovirus type 2 has demonstrated high mutation and recombination rates and is known to be rapidly evolving in Europe and worldwide. Commercial PCV2 vaccines have been efficacious in controlling the clinical disease, but there is a growing genetic gap between field viruses and vaccines. So far, all vaccines in Europe have been based on one single genotype, PCV2a, while today the most prevalent viruses found belong to other genotypes: PCV2b and especially PCV2d.
“We believe that there is a need for new vaccines, like CircoMax Myco which includes two PCV2 genotypes for a broader coverage. We found excellent results showing reduction of body weight gain losses in field trials in the EU. This innovative one-dose vaccine is a new tool for veterinarians and producers that may improve their PCV2 and M. hyopneumoniae control programs, especially in the face of multi-genotype PCV2 infections.”
Alvaro Aldaz, Director, Global Commercial Development, Swine, Zoetis, said: "For many years, intensive vaccination has contributed to selective pressure and emergence of new PCV2 genotypes. European pig farms are often infected with more than one genotype and subclinical disease is frequent. Commercial vaccines are all based on PCV2a genotype while CircoMax Myco is the first vaccine that includes two PCV2 genotypes (a & b), and the inventive M. hyopneumoniae purified fraction. It is formulated with MetaStim for active immunization, resulting in 23 weeks of protection against these threats."
CircoMax Myco contains inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2a open reading frame 2 (ORF2) protein, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2b ORF2 protein and inactivated Mycoplasma hyopneumoniae, strain P-5722-3.
The full eligibility criteria, including FAQs and guidance notes, for veterinary surgeons who wish to stand for RCVS Council can be found at: www.rcvs.org.uk/rcvscouncil21. The deadline for nominations is 5pm on Sunday 31 January 2021.
Due to the ongoing postal problems caused by the coronavirus pandemic, RCVS Council has approved a temporary change to the RCVS Election Scheme this year to allow nominations to be submitted electronically, rather than in hard copy. This temporary change is currently before the Privy Council for final approval.
Eleanor Ferguson, RCVS Registrar and Returning Officer for the elections, said: "For prospective RCVS and VN Councils election candidates this will mean that, rather than having to send us hard copies of your nomination documents in the post, these can simply be emailed to the College along with the relevant digital photographs and electronic signatures."
The College has also updated its information and guidance for prospective candidates, including an informal ‘job description’, to help them better understand what it means to be members of RCVS Council, their responsibilities, commitments and how they help the College meet its strategic goals, as well as the principles and rules governing their conduct.
Prospective candidates for RCVS Council can also contact RCVS President Dr Mandisa Greene for an informal conversation on what it means to be a Council member on president@rcvs.org.uk.
Mandisa said: “As I have often said publicly, when I decided to stand for RCVS Council it was out of a mixture of fear and curiosity, the RCVS seemed liked some distant organisation that was often talked about, but not entirely understood, and that made me want to find out more. It is fair to say that, since joining RCVS Council, I have learned and experienced a great deal, have got to know people in our profession that I would otherwise never have had the opportunity to meet, and have been at the forefront of key discussions about how our profession is regulated and its future.
"Throughout my time on Council I have also been a working mother of two young children and so, for those who are concerned about how being a Council member can fit around personal and professional life, I can assure you that there is flexibility that allows you to carry out your Council work around other commitments.
"I do hope that, if you are interested in the future of our professions and having a say in our professional and educational standards and how we are governed, then please take the time to consider becoming a member of RCVS Council and don’t hesitate to get in touch with me if you want to know anything more."
There is one more Council meeting before the nomination period ends. It will take place online on Thursday 21st January 2021 and prospective candidates who would like to get a feel for it are welcome to attend as observers: contact Dawn Wiggins, RCVS Council Secretary, on d.wiggins@rcvs.org.uk.
Written by members of BSAVA Scientific Committee, together with specialists in internal medicine and neurology, the document explains that there are limited studies showing beneficial effects of CBD, and those that there are need to be interpreted with caution as they involved small sample sizes and used unlicensed products which may have contained other components which could have influenced the results.
The document also explains that legally, CBD products must be prescribed by a veterinary surgeons and not used instead of a medication with proven efficacy.
Caroline Kisielewicz, BSAVA Scientific Committee member and one of the authors of the document said: “Information regarding the effects of cannabinoids on animals is predominantly at the stage of pre-clinical testing of individual substances in mice, rats and guinea pigs. There are limited clinical studies looking at the effects of CBD in dogs, and no reported studies in cats.
"There are many reports describing possible beneficial effects and therapeutic potential in humans, and subsequently pet owners may ask their vet about using cannabinoids to treat veterinary patients. This document aims to provide a broad overview of the available evidence base and legal position in the UK for veterinary team members."
BSAVA President, Ian Ramsey added: "The development of this information is in direct response to an increased interest in the use of CBD to treat cats and dogs. Furthermore, the guidance supports BSAVA’s mission to promote excellence in small animal practice through community, education and science."
The BSAVA position on CBD can be accessed here: https://www.bsavalibrary.com/content/chapter/10.22233/9781910443514.chap8#html_fulltext.
David Chalkley MRCVS faces four alleged charges:
At the start of the hearing Mr Chalkley made no admissions as to the charges but he had made an application for an adjournment based on undertakings to remove himself from the Register and never to apply to be restored to the Register.
In addressing the Committee on behalf of Mr Chalkley, his counsel said that Mr Chalkley denied all charges of dishonesty, that there was no evidence of harm to animals as a result of the alleged conduct, that there had been no complaint from the client and that he had repaid all the sums he had received for tuberculin testing on the farm in question.
His counsel also submitted that a full hearing would be expensive and time-consuming, and that it would serve no useful purpose as animal welfare and the protection of the public would be served by Mr Chalkley’s proposed undertakings.
Counsel on behalf of the RCVS confirmed that the College did not oppose the application and confirmed that the Animal Plant and Health Agency did not object.
However, the Disciplinary Committee concluded that because the case concerned issues of alleged dishonesty in veterinary certification over a prolonged period of time and the importance of public trust in the accuracy and reliability of that process, there was a need to hold a full, public hearing into Mr Chalkley’s alleged conduct.
Ian Arundale, chairing the Committee and speaking on its behalf, said: “The Committee expressed no view as to whether the allegations could be substantiated or not and it recognised that the process of determining the allegations would be burdensome for many, particularly the respondent.
"It was satisfied, however, that a reasonable and fully informed member of the public would be disturbed to learn that allegations of this kind had not been the subject of a formal determination by the Disciplinary Committee. The respondent’s own interests had to take second place to this important public interest.
“The Committee therefore declined to accept the application to adjourn this inquiry [until an unspecified date] and directed that arrangements should now be considered for the listing of a hearing in this case.”
It is expected that the full hearing will take place in spring 2021.
Faecal matter transplantation (FMT) has been used in people to treat Clostridium difficile infections and has also been trialled in conditions such as irritable bowel syndrome, Crohn’s disease and ulcerative colitis.
The researchers believe that FMT offers a potential new option for the treatment of chronic diarrhoea in dogs and the study will investigate whether it contributes to a more rapid resolution of clinical signs. The study is being conducted in association with eight other private practices or universities around the country.
Julien Bazelle, a European Veterinary Specialist in Small Animal Internal Medicine at Davies said: "The goal is to recruit, over a short period of time, canine patients with chronic small intestinal diarrhoea, for a randomised trial in which the cohort receives or not FMT at the time of the initial investigations and prior to any other treatment.”
Dogs aged 6 months to 10 years with a history of chronic small intestinal diarrhoea (+/- other GI signs) are needed to participate in the study. Half of the dogs will receive FMT and the other half will be managed without. FMT will be performed in eligible patients during the sedation for their routine abdominal ultrasound. Transplanted faecal matter will be administered via a retention enema.
To be eligible, dogs must not have received antibiotics, probiotics or steroids recently.
If you have a potentially suitable patient please contact: julien.bazelle@vetspecialists.co.uk or Fergus.Allerton@willows.uk.net
The Dairy Vet of the Year award, which is organised by the British Dairying Magazine and sponsored by Krka UK Ltd, recognises a veterinary surgeon for going the extra mile in helping to create a more positive, forward-thinking dairy industry.
In addition to her work as a farm vet, Sarah is also Technical Director at the TB Advisory Service (TBAS), which involves her overseeing and delivering training for new advisors, chairing technical board meetings and delivering farmer meetings across the country. She also provides bespoke advice to farmers in High Risk and Edge Areas of England, and is known for her compassion and understanding for those suffering a TB breakdown.
She is also a member of the TB Eradication and Advisory Group (TBEAG) for England, which advises government policy makers on all aspects of TB control in England.
Lindsay Heasman, Project Manager at TBAS, said: “Sarah is an authority on TB and understands the responsibility that comes with this role. She uses her position for good at all times and is prepared to make statements that are not always universally popular. By standing by her beliefs and dispelling misconceptions, she has won the respect of farmers across the country. Her dedication has, at times, come at personal cost, but her passion for eradicating bTB and support for farmers in achieving this goal never wavers.”
Sarah said: “I am just a farm vet doing the same job every farm vet does daily across the country. Through necessity, seeing my clients being devastated by TB breakdowns every day, I felt passionate about doing something about it. TBAS, my colleagues I am lucky to work with, and TBEAG have given me the platform to do this. I am very humbled that the judges though me worthy of the Award amongst the other hard-working vets."
Photo: Giles Brandreth, Charlotte Read, Sarah Tomlinson and Sean Sparling
Procapen contains a high dose of procaine benzyl penicillin, a narrow spectrum antibiotic which targets the most important pathogens in fresh cases of mastitis in cows and is the drug of choice against benzylpenicillin-susceptible streptococci and staphlococci.
Marcus Scott, Large Animal Business Manager at Forte said: "With the widespread shortage of intramammary tubes at the moment, Procapen provides a welcome solution for many mastitis cases."
For more information, contact your local Forte Territory Manager or email: enquiries@fortehealthcare.com.
According to the study1, which looked at Chihuahuas treated in first opinion practice, ownership in the UK has increased over five-fold in the past decade from 1.0% of all puppies born in 2005 to 5.4% in 2016.
However, the study also found the breed was particularly susceptible to a number of health issues, including: dental disease (13.5%), obesity (5.9%) and retained baby teeth (5.7%).
Compared with other dogs, Chihuahuas were also more prone to aggression (4.2%), slipping kneecap (4.0%) and retained testicles (3.9%).
Other findings included:
Dan O’Neill, senior lecturer at the RVC and author of the paper, said: "Chihuahuas are an old breed but the recent craze for them can cause some real welfare issues for this tiny dog. There is increasing evidence that unscrupulous breeders and dealers both inside and outside the UK are cashing in on this trend by making a lot of money but with little regard for the welfare of these puppies and breeding bitches."
Camilla Pegram, VetCompass epidemiologist at the RVC and co-author of the paper said: "Dental disease and retained baby teeth should be recognised as important health concerns for Chihuahuas, with preventative care for dental disease a key topic for discussion between vets and owners. In addition, many of the common or predisposed disorders, such as dental disease, retained baby teeth, sliding kneecap and retained testicle(s), often require surgical intervention. The Chihuahua’s small size increases its anaesthetic risk. Obesity has many detrimental effects, including increased anaesthetic risk, and aggression makes them challenging patients and pets, therefore nutrition, lifestyle and behaviour are also key areas for veterinary-owner discussions."
The full paper is open access: https://doi.org/10.1186/s12917-020-2258-1.
Reference:
The full day programme includes:
• Gastroprotectants in veterinary medicine – Julien Bazelle• An update on steroid responsive meningitis arteritis and meningoencephalitis of unknown aetiology – Jeremy Rose• An update on feline viral infections – Dr Jane Sykes• Guiding clinical decision making in Cushing’s syndrome – Imogen Schofield• What can’t TKIs be used for? – Aaron Harper• Case experiences – Professor Michael Herrtage
The society is also inviting entries for its Case Report competition, the deadline for which is the 6th March 2020.
The meeting costs £130 for members, £180 for non members and £75 for interns, residents and those graduating in 2020.
For more information and to register, visit: https://www.samsoc.org/meetings/2020-spring-meeting
Currently fewer than one in ten veterinary students opt to go into equine practice. BEVA says it hopes that the new scheme will provide a broader base of students with an insight into the world of equine veterinary medicine and open more eyes to what’s great about being an equine vet.
Katie Roberts the President of the Association of Veterinary Students said: "This is a very exciting opportunity for students. Anecdotally, we know that some students can feel very daunted by equine practice, especially if they don’t come from a traditionally horsey background. Being able to become involved with BEVA at no cost means that they can get a true taste of the equine veterinary world in addition to their experiences on EMS, and I’m sure this will pique the interest of our members."
As part of their free membership, students will also have access to:
The initiative has been made possible with sponsorship from Baker McVeigh, CVS Group, IVC, Newmarket Equine Hospital, Rossdales, VetPartners, and XLVets.
For further information about student membership of BEVA visit: https://www.beva.org.uk/Join-BEVA/vet-student
The deal is expected to complete by the middle of 2020.
According to the terms of the deal, Vetoquinol will acquire the Profender and Drontal product families, the intellectual property, registrations and other rights currently owned by Bayer AG’s animal health business.
Jeff Simmons, president and CEO of Elanco said: "We’re pleased with the continued progress on a number of fronts to move the acquisition of Bayer AG’s animal health business toward completion.
Matthieu Frechin, CEO of Vetoquinol, said: "We are very pleased to acquire the Profender and Drontal product lines that are highly valued by veterinarians and pet owners. The acquisition of these two strong brands is at the heart of our strategy. On the one hand, they will significantly increase the size of our business and our visibility in the parasiticide segment, one of our strategic therapeutic areas. On the other hand, they will strengthen our portfolio of Essentials, the engine of our growth."
The system consists of a number of small wireless sensors which are placed in each fridge and which transmit data to a base station. It records a temperature history for each fridge, transmitting the data in real time to secure cloud storage, from where it can provide reports on the changing temperature in each fridge for compliance and regulatory purposes.
RemoteM is self-installed and battery operated, and it transmits data using the mobile phone network, so it is not reliant on a power source or working internet connection. Temperature alarms can be sent to one or more recipients, using email, automated voice calls or SMS.
Dalehead Veterinary Group, which has practices in Settle, Bentham and Gisburn, began trialling the RemoteM system almost a year ago.
Dalehead has six fridges at its Settle practice. Before installing RemoteM, practice staff needed to record daily readings of fridge temperatures, taken at different times of the day. As well as being a time-consuming process, it risked being inaccurate, as simple in-fridge monitors do not record all fluctuations in temperature.
Practice Manager Emma Spence said: "RemoteM has already saved us at least £4,000.
"One of our small animal vaccine fridges failed overnight, and the instant alarm meant we were able to respond immediately, with our on-call vet moving the stock to another fridge without risk of deterioration. At various times of year when we can have high values of stock in individual large fridges, this could have been even more critical."
The practice says the system has also proved useful in alerting staff to fluctuating temperatures in warm summer months, helping to ensure that vaccines and medicines are used in optimum condition.
For this reason, RemoteM sensors are also used outside fridges to monitor stock held at ambient temperatures, where the alarm trigger is set at 25 degrees to ensure stock does not exceed manufacturers' recommended storage temperature limits.
Another benefit of the system has been that Dalehead's insurer has said that with RemoteM, it is happy for the practice to continue to use its older fridges, instead of stipulating that they are replaced every three years.
So, it's not just saving the practice money, then. It's helping reduce pollution too.
For more information, call 0330 223 4553, email: info@remotem.co.uk or visit: www.remotem.co.uk.
The book is described as giving comprehensive information to support the diagnosis and treatment of commonly seen pathologies of dogs and cats, such as haematology, immunology, diagnostic imaging, respiratory diseases, cardiovascular medicine, reproductive system disorders, gastrointestinal disorders, as well as hepatobiliary and exocrine pancreas disorders.
Each chapter has been authored by an internationally recognised expert in their field.
Improve says its books support delegates studying for its Postgraduate Certificate, but are also a useful reference source for other veterinary surgeons.
John Douglass, General Manager of Improve International, said: "Following the positive response to our first textbook, the Improve International Manual of Small Animal Surgery, we felt it was important to follow up with a small animal medicine equivalent. We’re therefore very happy to unveil volume one of the Improve International Manual of Clinical Small Animal Internal Medicine and look forward to the launch of the second volume later this year."
He added: "Our textbooks focus on the practical application of current veterinary knowledge, offering top tips and key advice throughout expressed in an engaging and highly visual format to ensure that they are perfect for those in need of a quick ‘look up’ in practice.”
The new books can be bought from www.improveinternational.com/uk/books, www.5mbooks.com or from booksellers worldwide. They are also available in Spanish with translations into additional languages planned.
The College says the aim of the programme, which will replace the current Professional Development Phase (PDP), is to ensure that new graduates are fully supported in their new role and able to progress from day one competencies into confident and capable independent practitioners.
The new programme builds on the results of the Graduate Outcomes Consultation, a consultation which reported in 2019 to gather the views of the profession with regards to day one competencies, the PDP, extra-mural studies and clinical education for general practice.
The Graduate Outcomes consultation found that the profession felt that support mechanisms for new graduates needed to be strengthened, and the proposal to develop this new programme of support was approved by RCVS Council in January.
The first of the two working groups is the EPA Working Group, which is tasked with assisting the development of a bank of Entrustable Professional Activities (EPAs). EPAs describe the everyday professional tasks carried out by vets in practice, covering a wide range of areas of clinical and professional practice which graduates and their mentors can access to build into their own e-portfolio.
The second working group is the Mentor Working Group, which will assist in shaping the role of the mentor in the new programme and create a training package for workplace mentors.
Sue Paterson, Chair of RCVS Education Committee said: "It is incredibly important for us to have input from veterinary surgeons who are working in general practice as they are well positioned to comment on how the development programme can effectively support graduates on a day to day basis."
The College is looking for veterinary surgeons working in practice and who have an interest in helping new graduates gain the best possible experience to join as members of these new working groups. It would be beneficial for applicants to have experience with mentoring and/or workplace training.
Successful applicants would be required to visit the RCVS for three half-day meetings over the period of a year and the RCVS would cover travel and subsistence expenses. There would be an additional time commitment to review and feedback on material via email.
Those general practitioners who are interested in applying should email Britta Crawford, RCVS Education Manager, via b.crawford@rcvs.org.uk giving a brief description of their current position and why they feel they would be an asset to the working group. The closing date for applications is 6 March 2020.
This, says the company, will make vaccination easier for vets and clients.
Eravac is an injectable emulsion ready for administration without the need for reconstitution beforehand.
Each box contains 10 individual doses which can be given to pet rabbits from 30 days of age.
Ceva says the course is aimed at vets and nurses who want to build their confidence and take the lead in finding hypertension in cats in their clinic.
The course is hosted by Sarah Caney BVSc DSAM(Feline) MRCVS, one of the UK's leading specialists in feline medicine, and will cover things like finding out which cats need screening for feline hypertension, how to become confident in recommending a blood pressure check to owners, hints and tips on taking a reliable blood pressure measurement and handling cats calmly to reduce ‘situational hypertension’.
The course consists of four 30-minute recorded sessions including course notes and self-assessment questions for each module. Once completed, the delegate will receive a Hypertension Ambassador pin badge and a certificate for four hours’ CPD. The first 500 delegates to complete the course will be offered either a cat hide or an eye atlas.
The course can be completed online at any time. There are also weekly feline hypertension live sessions at 1pm, from Wednesday 4th March until Wednesday 25th March. They offer the opportunity for you to ask questions, but they're also recorded so you can watch them any time thereafter.
Suzanne Page BVSc MRCVS, cardio-nephrology-hypertension product manager at Ceva Animal Health, said: "Our HypertensionAmbassadors’ initiative will educate veterinary professionals on every aspect of feline hypertension to enable them to confidently talk to their clients about the condition, measure blood pressure in a cat-friendly way and offer advice on the different treatments available."
For more information, and to register, visit www.veterinarywebinars.com/feline-hypertension-ambassador.
Procanicare contains three live strains of canine-specific Lactobacillus bacteria, which, according to the company, make it an ideal GI support product to maintain balance in the GI intestinal microbiome of dogs, particularly when an alteration to the intestinal microbiome is a risk.
Animalcare says studies show that the strains of Lactobacillus found in Procanicare have been shown to promote indigenous intestinal commensal populations, reduce numbers of potentially pathogenic bacteria and improve stool consistency.1,2
Dr Shea Beasley, Product Development Manager at Vetcare Ltd said: "The strains of Lactobacillus found in Procanicare have been commercially available in Scandinavia for two years now. It has achieved great success, with Scandinavian vets frequently recommending it in situations where the gastrointestinal microbiota can become unstable such as following antibiotic use and in stressful situations such as travelling and kennelling, as well as when supporting the intestinal microbiome is particularly important, such as during pregnancy and lactation."
Available exclusively through vets, Animalcare has produced a range of waiting room materials to help you educate about and promote Procanicare in practice, including a poster, bunting, leaflet and leaflet holder.
There is also a free webinar for veterinary professionals on the importance of the intestinal microbiome, available to view at www.thewebinarvet.com/webinar/the-gastrointestinal-microbiome-and-its-effects.
To find out more or to try Procanicare in your practice, contact your local Animalcare representative via email animalcare@animalcare.co.uk or telephone 01904 487687 or visit www.procanicare.com.
References
The chewable, prescription-only tablet contains sarolaner, which kills fleas and ticks; moxidectin, for the prevention of heartworm, lungworm disease and for the treatment of some intestinal worms; and pyrantel embonate, for the treatment of gastrointestinal nematodes (hookworms and roundworms).
Professor Tim Geary, BSc PhD, Professor Emeritus, Institute of Parasitology, McGill University, Canada, and Professor, School of Biological Sciences, Queen’s University, Belfast, a consultant to Zoetis, said: “Serious diseases that are preventable and of increasing prevalence threaten dogs in Canada and Europe. Simparica Trio today offers a better solution to preventing and controlling these parasites against the concern of their increasing prevalence."
Rob Kelly, President, International Operations at Zoetis said: "With Simparica Trio, we bring to market an advanced parasiticide solution, helping to deliver improved client satisfaction and patient protection.
"Thanks to its broad spectrum, Simparica Trio helps veterinarians and dog owners provide more complete parasite coverage with a single-monthly chewable tablet. The broad spectrum of Simparica Trio minimises the potential risk of parasite protection gaps."
Simparica Trio is indicated for dogs from at least eight weeks of age and 1.25 kg and will be available in six tablet strengths for dogs of all sizes.
For more information about Simparica Trio and full prescribing information, visit www.zoetis.com.
The Committee had found Dr Elefterescu guilty of serious professional misconduct in relation to a number of charges which covered issues such as dishonesty, poor record-keeping, and failure to carry out adequate clinical examinations.
The full charges and findings of the RCVS Disciplinary Committee can be found at: www.rcvs.org.uk/disciplinary.
The Judicial Committee of the Privy Council held the appeal hearing in October last year with three Justices of the Supreme Court - Lord Kerr, Lord Carnwath and Lord Kitchin – comprising the Board.
The basis of the appeal to the Privy Council was that the Committee’s findings on the facts of the case were flawed, with his counsel saying that Dr Elefterescu 'strenuously disputes the findings by the Committee of his dishonesty and lack of professional competence and submits that there is no adequate basis for them in the evidence’.
His counsel also told the Board that the Disciplinary Committee’s sanction failed to take into account mitigating factors and that the decision to remove Dr Elefterescu from the Register was disproportionate.
In relation to the appeal against the Disciplinary Committee’s findings on the facts, the Board was not persuaded by any of the arguments put forward on behalf of Dr Elefterescu. These arguments included that the RCVS had failed to call relevant witnesses and had failed to make Dr Elefterescu aware of the significance of some evidential matters, disclosed to him.
In respect of the sanction, the Board was also unpersuaded by the arguments put forward by Dr Elefterescu’s counsel, namely that it was too harsh in its assessment of aggravating factors, did not give adequate weight to mitigating factors, and that it failed to distinguish lack of competence from misconduct.
In its judgment on the arguments put forward by Dr Elefterescu’s counsel, the Board said: "It is the opinion of the Board that these criticisms are not well founded. The Committee considered with care Dr Elefterescu’s proven and admitted conduct in relation to each of the charges and whether it fell below or far below the standard to be expected. It is to be noted in this regard that a number of the charges which were either admitted or upheld were not the subject of any challenge on this appeal.
"Overall, the Committee found that Dr Elefterescu’s clinical failures were very serious, involved failures in the basics of animal care, resulted in animal suffering and involved widespread breaches of the respondent’s [RCVS] code of professional conduct. It also expressed particular concern about its findings of dishonesty, and rightly so. That conduct was, in its view, ‘at the top end’ of disgraceful conduct in a professional respect. What is more, Dr Elefterescu had a lack of insight into his failings and a wholly unjustified confidence in his abilities which constituted an ongoing risk to animal welfare."
"These were findings which the Committee was clearly entitled to make and, in the light of them, the Board is firmly of the view that the decision of the Committee to direct the removal of Dr Elefterescu’s name from the Register cannot be impeached. The Board rejects the criticisms made of the Committee’s reasoning and the conclusions to which it came. The direction that Dr Elefterescu’s name must be removed from the Register was appropriate and proportionate."
The Judicial Committee’s full findings can be found at www.jcpc.uk/cases/docs/jcpc-2018-0060-judgment.pdf.
Speakers at the event will include Andrew Sparkes, BVetMed, PhD, DipECVIM, MANZCVS, MRCVS (pictured right) and Ebenezer Satyaraj, PhD.
BSAVA Congress delegates can register for the free symposium, which also includes lunch, at www.tickettailor.com/events/purina/349478.
Libby Sheridan, MVB MRCVS, Purina Veterinary Technical Affairs Manager, said: "Veterinary professionals often see the consequences of sensitivities to cat allergens - which for some, it may even mean relinquishment of the pet with all the emotion attached around that event. This symposium will focus on the consequences for cat welfare and how the profession can help support their cat-owning clients through a breakthrough approach."
The new approach is based on neutralising the major cat allergen in cats' saliva, Fel d 1, through feeding a cat food coated with an egg product ingredient containing anti-Fel d 1 antibodies.
This, says the company, helps to reduce the active allergen transferred to hair and dander during grooming, and ultimately helps reduce active Fel d 1 in the environment.
Dr Sparkes is a diplomate of the European College of Veterinary Internal Medicine and the founding and current co-editor of the Journal of Feline Medicine and Surgery, the official journal of ISFM and the American Association of Feline Practitioners. He will be sharing his review of the literature around feline relinquishment.
Dr. Satyaraj is a member of the American Association of Immunologists and the American Veterinary Immunology Association and a reviewer for several journals including the British Journal of Nutrition and Arthritis & Rheumatism. He is also a Fellow of the Academy of Science in St Louis and a leading scientist at the Purina Institute. Dr Satyaraj will be focusing on the studies supporting this important area of research.
The symposium provides 1.5 hours of certified CPD. More information about the science is available at www.purinainstitute.com.